All Type of News
Collision between ruling and opposing parties over Moon Jae-In Care
At the National Assembly inspection for the Ministry of Health and Welfare, ruling and opposing parties crashed over ‘Moon Jae-In Care.’
At the National Assembly inspection for the Ministry of Health and Welfare on t...
Rebates were increased instead? Needing special measures for this
Despite pharmaceutical companies’ efforts of eradicating rebates through ethical business management, the number of illegal rebate offenders were increasing for the past 3 years and there have been still reportedly a ...
Daewoong Pharmaceutical acquires sale right and license of Sandoz’s osteoporosis treatmentDaewoong Pharmaceutical(CEO Jong-Wook Lee) announce the company acquired a Korean sale right and license of ‘Zoledronic Acid Inj 5mg/100ml,’ a osteoporosis treatment, from Novar...
|
Which are pharmas having top 100 most reported products for side effect?
A report about side effects of influential pharmaceutical companies’ multiple products for the past 5 years between 2013 and 2017 was reportedly made.
According to the ‘Top 100 Most Reported Products for Adverse Drug...
Some foreign pharmas’ confusing indication of expiration date interrupts pharmacists
Pharmaceutical companies’ method of indicating expiration date has created confusion on consumers, which caused difficulties to pharmacists in the field.
According to the pharmacy circles, pharmacists have frequently...
Yuhan Corporation & Samsung Bioepis sign exclusive biosimilar sales agreement
Yuhan Corporation(CEO Jung-Hee Lee) signed an exclusive sales agreement of the Remicade(generic name: infliximab) biosimilar(SB2) and the Enbrel(generic name: etanercept) biosimilar(SB4) in Korea with Samsung Bioepis(...
What are things to focus for the new government’s first parliamentary inspections?
The new government’s first parliamentary inspections have begun. In the meantime, the pharmaceutical/bio-tech industry has focused on various issues including an issue related to ‘Moon Jae-In Care.’
The National Asse...
Diabetes patients reach 12.17 million in 5 years, costing KRW 8.511 trillion
Patients with diabetes, the most common adult disease of Korea, have been increasing for the past 5 years.
According to a report The Minjoo Party Rep. Dong-Min Ki received from the Health Insurance Review and Assessm...
Lilly’s Trulicity applied for national health insurance benefit in combination with insulin
Lilly Korea(CEO Paul Henry Huibers) announced the Ministry of Health and Welfare’s national health insurance benefit standards were extensively revised under a revision bill for ‘Trulicity(generic name: dulaglutide)’ ...
Rapid increase of side effects for emergency household medicines after being sold at convenient stores
It was criticized sales of emergency household medicines at convenient stores, which has been implemented since 2012, have rather threatened based on many reports about their side effects.
The Minjoo Party Rep. Choon...
